Furthermore, in glioblastoma, H19 reduced expression of Nkd1, which is a Wnt pathway inhibitor, via EZH2-mediated epigenetic regulations (61), and its overexpression increased angiogenesis in in-vitro investigations (46). The gene discussed is H19; the disease is glioblastoma.